dc.contributor.author | Russell, MA | |
dc.contributor.author | Foulis, AK | |
dc.contributor.author | Krogvold, L | |
dc.contributor.author | Dahl-Jorgensen, K | |
dc.contributor.author | Richardson, SJ | |
dc.contributor.author | Morgan, NG | |
dc.date.accessioned | 2017-07-27T12:58:08Z | |
dc.date.issued | 2017-03-08 | |
dc.description.abstract | Diabetes UK Professional Conference Abstract | en_GB |
dc.identifier.citation | Vol. 34, supplement S1, p. 40, abstract P13 | en_GB |
dc.identifier.doi | 10.1111/dme.1_13304 | |
dc.identifier.uri | http://hdl.handle.net/10871/28668 | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley for Diabetes UK | en_GB |
dc.rights.embargoreason | Publisher policy | en_GB |
dc.rights | © 2017 The Authors, presented at the Diabetes UK Professional Conference. © 2017 Diabetes UK. | en_GB |
dc.title | Major histocompatibility complex class II (MHCII) and its transcriptional regulator, CIITA, are aberrantly expressed in discrete beta cells in individuals with Type 1 diabetes | en_GB |
dc.type | Article | |
dc.identifier.issn | 0742-3071 | |
pubs.declined | 2017-07-27T11:46:11.610+0100 | |
dc.description | This is the author accepted manuscript. The final version is available from Wiley via the DOI in this record. | en_GB |
dc.description | Special Issue of Diabetic Medicine: Abstracts of the Diabetes UK Professional Conference 2017, Manchester Central, Manchester, 8–10 March 2017 | en_GB |
dc.identifier.journal | Diabetic Medicine | en_GB |
refterms.dateFOA | 2018-03-01T00:00:00Z | |